Expiring federal contract
75H71025P00975 — Becton, Dickinson And Company
Department of Health and Human Services · Indian Health Service
- Contract / PIID
- 75H71025P00975
- Incumbent
- Becton, Dickinson And Company
- Incumbent UEI
- DP4CNEMUF5F3
- Current end date
- November 30, 2026
- Potential total value
- $102,500
- Obligated
- $102,500
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 — LABORATORY EQUIPMENT AND SUPPLIES
- Set-aside
- Full & Open
- Start date
- August 29, 2025
- Place of performance
- AZ
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
FY2025 BPA FOR LAB SUPPLIES AND REAGENT KITS TO BE ORDERED ON AN 'AS NEEDED' BASIS FOR THE BO FX AUTOMATED BLOOD CULTURE SYSTEM
Likely rebid window (estimate)
- Sources Sought / RFI: about Nov 2025 – May 2026 (6–12 months before the end date)
- RFP: about Jul 2026 – Sep 2026 (2–4 months before the end date)
In the final months before the current end date.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M